Health Insurance Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ben-Gurion University, Israel
Interferon-alpha therapy contributes to weight loss by increasing adipocyte apoptosis
August 13th, 2006
Increased apoptosis of adipocytes contributes to weight loss following interferon-alpha therapy. "Interferon alpha (IFN-alpha) is produced in response to viral infections and used clinically in the therapy of a variety of cancers and viral infections. IFN-a treatment is often associated with severe weight reduction. To elucidate the mechanism of IFN-associated weight loss, we studied its effect on adipocytes in vitro and in vivo. Diet-induced obese (DIO) C57BL/6 mice were treated continuously for 8 days with human IFN-alpha A/D (100 U/g body weight) or with vehicle alone," researchers in Israel report. "The body weight and adipose cell size of...
Source: Health Insurance Law Weekly (2006-08-13)
|
